Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Journal of Biopharmaceutical Statistics|April 25, 2019
Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomizationYunyun Jiang, Wenle Zhao, Valerie Durkalski-MauldinStatistical Methods in Medical Research|November 19, 2016
The asymptotic maximal procedure for subject randomization in clinical trialsWenle Zhao, Vance W Berger, Zhenning YuContemporary Clinical Trials|September 4, 2017
Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpointYunyun Jiang, Wenle Zhao, Valerie Durkalski-MauldinStatistical Methods in Medical Research|January 31, 2012
Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocationWenle Zhao, Michael D Hill, Yuko PaleschClinical Trials (London, England)|January 20, 2010
A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depressionValerie Durkalski, Wenle Zhao, Catherine Dillon, et al.Statistical Methods in Medical Research|January 15, 2015
A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trialsAmy S Nowacki, Wenle Zhao, Yuko Y PaleschContemporary Clinical Trials|November 17, 2010
Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomizationJody Ciolino, Wenle Zhao, Renee' Martin, et al.Pharmaceutical Statistics|May 6, 2011
Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomnessWenle Zhao, Yanqiu Weng, Qi Wu, et al.Contemporary Clinical Trials|February 2, 2015
Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergenciesWenle Zhao, Yunming Mu, Darren Tayama, et al.Journal of Biopharmaceutical Statistics|May 27, 2015
Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rateYanqiu Weng, Yuko Y Palesch, Stacia M DeSantis, et al.Pageof 6